ATE345131T1 - Topische verabreichung vasoaktiver vitamin b3 verbindungen zur schlafförderung - Google Patents

Topische verabreichung vasoaktiver vitamin b3 verbindungen zur schlafförderung

Info

Publication number
ATE345131T1
ATE345131T1 AT04776913T AT04776913T ATE345131T1 AT E345131 T1 ATE345131 T1 AT E345131T1 AT 04776913 T AT04776913 T AT 04776913T AT 04776913 T AT04776913 T AT 04776913T AT E345131 T1 ATE345131 T1 AT E345131T1
Authority
AT
Austria
Prior art keywords
vasoactive
vitamin
compounds
topical administration
promote sleep
Prior art date
Application number
AT04776913T
Other languages
English (en)
Inventor
James Patrick Ebel
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE345131T1 publication Critical patent/ATE345131T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04776913T 2003-06-13 2004-06-14 Topische verabreichung vasoaktiver vitamin b3 verbindungen zur schlafförderung ATE345131T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/461,701 US20040254202A1 (en) 2003-06-13 2003-06-13 Method of promoting sleep using topical administration of vasoactive agents

Publications (1)

Publication Number Publication Date
ATE345131T1 true ATE345131T1 (de) 2006-12-15

Family

ID=33511318

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04776913T ATE345131T1 (de) 2003-06-13 2004-06-14 Topische verabreichung vasoaktiver vitamin b3 verbindungen zur schlafförderung

Country Status (8)

Country Link
US (1) US20040254202A1 (de)
EP (1) EP1633334B1 (de)
AT (1) ATE345131T1 (de)
CA (1) CA2527366C (de)
DE (1) DE602004003241T2 (de)
ES (1) ES2277292T3 (de)
MX (1) MXPA05013393A (de)
WO (1) WO2005002554A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080199538A1 (en) * 2006-01-10 2008-08-21 Yronne Filopelrick Compound to enhance lucid erotic dreams

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1182320A (en) * 1967-12-21 1970-02-25 Ed Geistlich Sohne A G Dihydroorotic and Salts
FR2277579A1 (fr) * 1974-07-10 1976-02-06 Ucc Nouveaux medicaments contenant la methyl-6-diphenyl-3,4-tetrahydro-3,4,5,6-pyrone-2
GB1510583A (en) * 1976-03-26 1978-05-10 Gen Foods Corp Caffeine antagonists
DE2841170A1 (de) * 1978-09-21 1980-04-03 Pharmazeutische Praeparate Apo Hypnotikum
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
FR2531713A2 (fr) * 1981-09-16 1984-02-17 Panmedica Sa Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant
CA1184418A (en) * 1983-04-15 1985-03-26 Mary Maclean Natural coffee
GB8330969D0 (en) * 1983-11-21 1983-12-29 Wellcome Found Promoting healing
US4968684A (en) * 1987-04-01 1990-11-06 Janssen Pharmaceutica N.V. Method of improving sleep
US4965252A (en) * 1988-06-28 1990-10-23 Hauser-Kuhrts, Inc. Cholesterol-lowering combination compositions of guar gum and niacin
GB2252905B (en) * 1991-02-11 1995-05-10 Leung Lit Hung An agent for correcting a deficiency of androgenic steroids
AU660336B2 (en) * 1991-10-18 1995-06-22 Alza Corporation Device for the transdermal administration of melatonin
DE4334919A1 (de) * 1993-10-13 1995-04-20 Liedtke Pharmed Gmbh Grenzwertig wirksame Arzneiformen mit Betablockern
US5496827A (en) * 1994-07-15 1996-03-05 Patrick; Jay Compositions for the transdermal delivery of nutrients
WO2000007556A1 (en) * 1998-08-05 2000-02-17 Lorraine Mignault Topical lotion containing oatstraw
IT1306141B1 (it) * 1999-05-17 2001-05-30 Giampiero Valletta Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
US6596266B2 (en) * 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
JP2003523405A (ja) * 2000-02-22 2003-08-05 セレジー カナダ インコーポレイテッド 睡眠改善のための方法および組成物
CA2441461C (en) * 2000-04-14 2007-07-10 Niadyne Corporation Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia
US6464992B2 (en) * 2000-04-14 2002-10-15 University Of Kentucky Research Foundation Topical micronutrient delivery system and uses thereof
US20040054337A1 (en) * 2002-09-17 2004-03-18 Jiongyao Chen Method and device of reflexology
US20040191278A1 (en) * 2003-03-31 2004-09-30 Christensen Flemming Kjaergaar Topical agent for application to the skin prior to luminous treatment

Also Published As

Publication number Publication date
WO2005002554A3 (en) 2005-06-16
DE602004003241T2 (de) 2007-05-31
WO2005002554A2 (en) 2005-01-13
HK1089361A1 (en) 2006-12-01
EP1633334A2 (de) 2006-03-15
US20040254202A1 (en) 2004-12-16
EP1633334B1 (de) 2006-11-15
DE602004003241D1 (de) 2006-12-28
ES2277292T3 (es) 2007-07-01
MXPA05013393A (es) 2006-03-09
CA2527366C (en) 2009-04-07
CA2527366A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
TW200600111A (en) Improved dental whitening method
GB0420888D0 (en) Compounds and uses
MXPA05009694A (es) Metodos para mejorar la calidad de la piel.
NO20071742L (no) Kinazoliner som er nyttige som modulatorer av ionekanaler
ATE468332T1 (de) Phenyl-(4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin- - yi)aminderivate
UA85574C2 (uk) Ендопаразитоцидний засіб для місцевого застосування
MY158428A (en) Topical composition for the treatment of actinic keratosis
BR0315878A (pt) Melatonina em formulações cosméticas
MX2007006539A (es) Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel.
NO20071798L (no) Dermalt pafore formuleringer for behandling av hudsykdommer i dyr
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
DE602004019528D1 (de) Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
MX2007013230A (es) Uso de una formulacion en aerosol de clobetasol para tratar psoriasis.
WO2004043424A8 (en) Method of stimulating hair growth using benzopyrans
ATE345131T1 (de) Topische verabreichung vasoaktiver vitamin b3 verbindungen zur schlafförderung
UY29069A1 (es) Uso de compuestos tpo miméticos y composiciones farmacéuticas para el tratamiento de la anemia
BRPI0621347B8 (pt) composição farmacêutica para aumentar a produção de eritrócitos e para o tratamento de anemia
EA201070334A1 (ru) Пиперидиниламинотиено[2,3-d]пиримидиновые соединения для лечения фиброза
BRPI0514815A (pt) método para tratar um distúrbio de pele hiperproliferativa, e, composição farmacêutica
ATE489073T1 (de) Melatonin-tagesdosierungseinheiten
ATE424896T1 (de) Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst
TNSN05117A1 (en) Formulations containing melatonin, ginkgo biloba, and biotin
SE0203536D0 (sv) Use of a known substance for the treament of cancer and bacterial and fungal infections
TW200726465A (en) Anti-inflammatory analgesic agent

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties